BACKGROUND: Angiomyolipoma (AML), typically composed of smooth muscle, vessels, and fat, is generally a benign tumor in the kidneys. However, it occasionally occurs in extrarenal sites and behaves like a malignant tumor. AML is uncommonly encountered in fine-needle aspiration (FNA) samples and can cause diagnostic difficulty. METHODS: We searched our pathology database for FNA cases diagnosed between 2003 and 2015 that were subsequently confirmed to be AML in the same lesion by surgical pathologic evaluation. The diagnostic performance, challenges, and cytologic features were retrospectively reviewed. RESULTS: In total, 33 FNA cases from 31 patients were identified. The final surgical pathologic diagnoses included 30 primary AMLs (28 in kidneys and 2 in liver) and 3 were metastases (in liver, lung, and abdominal wall, respectively). Aspiration sites included kidney/retroperitoneum (n 5 28), abdominal wall (n 5 1), lung (n 5 1), and liver (n 5 3). The FNA diagnoses were consistent with/favor AML (n 5 16), descriptive (n 5 12), nondiagnostic (n 5 2), and erroneous (n 5 3). Of the 3 erroneous cases, 2 were diagnosed as renal cell carcinoma, and 1 was diagnosed as a pleomorphic malignant neoplasm. Cytologically, cases with predominantly spindle cells were the most commonly encountered (n 5 19). Cases with predominantly epithelioid cells (n 5 6) can pose a diagnostic difficulty and were observed in all 3 metastatic AMLs and in 2 of the 3 erroneous cases. Immunostains were performed on 11 FNAs and helped the diagnosis in 9 cases. CONCLUSIONS: FNA diagnosis of AML may be challenging, especially in cases with a predominantly epithelioid component and/or an extrarenal location. Immunostaining is important to improve diagnostic accuracy of this rare entity.
INTRODUCTION
Angiomyolipoma (AML), which is composed of variable admixtures of blood vessels, smooth muscle, and mature fat, is an uncommon mesenchymal neoplasm that belongs to a family of perivascular epithelioid cell tumors. 1, 2 Typically, AML is a benign tumor that arises in the kidney, with rare extrarenal occurrences. AML often affects middle-aged women and occurs sporadically, as an isolated tumor, but it can be associated with tuberous sclerosis, in which patients have multifocal, smaller and bilateral renal tumors. 1, 3 With the advent of high-resolution imaging techniques, AML has been increasingly detected during radiologic staging or/and follow-up in patients with a history of malignancy or during a workup for other medical indications. AML with typical radiologic findings (ie, high fat content) or associated with tuberous sclerosis is usually managed with observation. 4 However, AML with atypical radiologic features (ie, no or limited fat content) and/or with clinical concern may trigger a pathologic evaluation. 5 Symptomatic or large tumors are likely to be treated by surgical resection. Histologically, AML is composed of variable proportions of abnormal, thick-walled vessels, smooth muscle (spindle and/or epithelioid in shape), and mature adipocytes. 1 Epithelioid AML is defined as a tumor that is composed predominantly of epithelioid cells. [6] [7] [8] Fine-needle aspiration biopsy (FNA) is a simple and cost-effective procedure that is often used as an initial diagnostic tool to evaluate mass lesions. To date, the published FNA cytologic studies of AML have been mostly single case reports or small series containing 2 to 8 cases. [9] [10] [11] [12] [13] [14] [15] [16] An FNA diagnosis of AML can be challenging because of sampling error and a lack of intact histologic architecture. The current study included a large number of AML cases sampled with FNA in various clinical scenarios. The objective of this retrospective study was to evaluate the diagnostic performance, cytologic features, and diagnostic pitfalls of this entity with the hope of improving diagnostic accuracy in the future and avoiding unnecessary surgery.
MATERIALS AND METHODS
We retrospectively searched our institution's pathology database for surgical pathology (core-needle biopsy or resection) cases with a final diagnosis of AML for which the same lesion had a precedent or concurrent FNA diagnosis between 2003 and 2015. We identified 33 cases from 31 patients. One patient had 3 FNA cases.
Aspirates were obtained by radiologists using a 20-gauge or 22-gauge needle under imaging (computed tomography or ultrasonography) guidance. An average of 2 FNA passes were made per case. Direct smears were air dried for Diff-Quik staining (Stat Lab, Lewisville, Tex) or fixed in modified Carnoy fixative (at a 6:1 ratio of 70% ethanol to glacial acetic acid) for Papanicolaou staining. The smears were assessed immediately by an onsite cytopathologist for specimen adequacy. The cells obtained from the needle rinses were subjected to centrifugation; the sediment was then fixed in a 50:50 mixture of 95% ethanol and 10% formalin and was embedded in paraffin to make the cell block (available in 19 cases). The cell block was then sectioned and stained with hematoxylin and eosin, and unstained slides were used for immunostaining.
Cytomorphologic information was available in 25 FNA cases, of which 19 cases had available slides for review and 6 had cytologic descriptions in the reports. We retrospectively analyzed the cytologic features for cellularity, cellular composition, and immunostaining results. The study was approved by the Institutional Review Board of The University of Texas MD Anderson Cancer Center.
Immunostains were performed on cell-block sections or Papanicolaou-stained, direct smears at the time of cytologic diagnosis. The antibodies most commonly used were those against HMB45 (1:50 dilution; Dako Corporation), melan-A (clone A103 [1:50 dilution]; Neomarker/Labvison), and smooth-muscle actin (SMA) (clone 1A4 [1:80,000 dilution]; Sigma-Aldrich).
RESULTS

Patient Demographics, Radiology, and Diagnoses
Thirty-three AML cases from 31 patients (9 men and 22 women) were identified. Their clinical, radiologic, and pathologic characteristics are summarized in Table 1 . Cases 30, 31, and 32 were from the same patient. The mean age of the 31 patients at the time of cytologic diagnosis was 58 years (range, 31-83 years). Twenty-five patients were asymptomatic, and the other 6 patients presented with hematuria, abdominal pain, or unrelated symptoms. Eighteen patients had a known history of malignancy, and the masses were identified during image surveillance; in 10 patients, the renal masses had been identified incidentally during imaging workup for other medical issues. Three patients had a known history of AML at the time of FNA. No patient had tuberous sclerosis identified. The final histologic diagnoses were primary AML in 30 cases (28 in the kidney/retroperitoneum and 2 in the liver) and metastatic AML in 3 cases (in the abdominal wall, lung, and liver; cases 31, 32, and 33, respectively).
On the basis of the radiology information available at the time of FNA, the size of the 33 masses ranged from 1.2 to 32 cm (average, 5.5 cm), and 9 of which measured > 5 cm. Of these, 3 tumors involving the retroperitoneum (cases 21, 22, and 24) measured 32 cm, 27 cm, and 8 cm, respectively. The aspiration sites included the kidney (n 5 25), kidney/retroperitoneum (n 5 3), liver (n 5 3), abdominal wall (n 5 1), and lung (n 5 1). The radiologic impressions of these lesions varied from primary renal tumor to metastatic neoplasm (Table 1) . AML was considered in the imaging diagnosis in 12 cases, of which AML was favored in 5 cases. Notably, renal cell carcinoma (RCC) was listed as a possible image diagnosis in 9 cases, and a lipomatous tumor/fatty mass was considered in 5 cases. A metastatic neoplasm was often considered in patients who had a history of malignancy.
Original Article FNA diagnoses included "consistent with or favor AML" in 16 cases (49%), descriptive (such as "rare spindle or epithelioid cells," "spindle cell proliferation," or "spindle cell neoplasm") in 12 cases (36%), nondiagnostic in 2 cases (6%), and erroneous in 3 cases (9%).
The 3 lesions with erroneous FNA diagnoses were located in the kidney; 2 (cases 26 and 27) were misdiagnosed as "RCC, clear cell type." Both patients had a known history of malignancy, and AML was not considered during the imaging analysis. The third lesion (case 28) was diagnosed as a "pleomorphic malignant neoplasm," although the patient had a known history of epithelioid AML, status post nephrectomy, and the radiologic findings suggested a recurrent AML in the kidney bed. Immunostains were performed on 1 of the 3 lesions (case 26), but the panel was not designed to detect AML. The final histologic diagnoses of the 3 masses were metastatic pancreatic neuroendocrine carcinoma in an AML, epithelioid AML, and recurrent epithelioid AML, respectively. It is noteworthy that metastasis within a renal AML was identified in 2 lesions. In addition to case 26, another lesion was an AML with metastatic carcinoma (case 5).
Cytologic and Immunostaining Evaluation
Of the 25 cases for which cytomorphologic information was available, cellularity was high, moderate, and low in 10 (40%), 12 (48%), and 3 (12%) cases, respectively ( Table 2 ). The typical features of AML were smoothmuscle cells intimately admixed with adipocytes and blood vessels, although the proportion of the 3 components varied considerably (Fig. 1) . Smooth-muscle cells, mostly spindle-shaped, with or without epithelioid forms were identified in all 25 cases, including 8 with predominantly spindle cells and 17 with both spindle and epithelioid cells. Of the latter, 6 cases (24%) were composed of predominantly (>50%) epithelioid cells (cases 24, 27, 28, 31, 32, and 33) (Fig. 1) . The other 2 components of AML, adipocytes and vascular elements, were less commonly observed and were identified in 8 (32%) and 11 (44%) cases, respectively. Only 6 cases (24%) demonstrated all 3 components.
The smooth-muscle cells were spindle or epithelioid (ie, round to polygonal in shape) with indistinct cell borders; fibrillary or finely vacuolated cytoplasm; and round, oval, or cigar-shaped nuclei with fine chromatin and inconspicuous nucleoli. Some cases, especially those with predominantly epithelioid cells, showed variable degrees of nuclear atypia, including nuclei enlargement, pleomorphism, prominent nucleoli, and occasional mitosis and necrosis. Bare nuclei, occasional intranuclear inclusions, and multinucleated giant cells were identified in some cases.
Notably, the 3 metastatic AMLs (cases 31, 32, and 33) (Fig. 2) and 2 of the 3 misdiagnosed lesions (cases 7 and 28) were composed of predominantly epithelioid smooth-muscle cells. The cells in case 28 were markedly pleomorphic, leading to an erroneous FNA diagnosis of "pleomorphic malignant neoplasm," although the history and radiologic information indicated a high possibility of AML (Fig. 3) . Case 24 was also composed of predominantly epithelioid cells; the FNA report of this lesion was descriptive, stating that adipose tissue was not identified in the FNA sample, although it was visible on the image; thus, the differential diagnosis included AML, angiolipoma, liposarcoma, and RCC. The final diagnosis of epithelioid AML in this lesion was rendered on the basis of histologic and characteristic immunostaining findings (ie, positive for HMB45 and negative for cytokeratin) using a core-needle biopsy sample. Immunostaining was performed in 11 cases (using cell-block sections in 10 cases and a Papanicolaoustained smear in 1) and was contributory to the diagnosis of AML in 9 cases (Fig. 4) . HMB45 was the marker used in 10 cases; it was positive in 8 cases and negative in 2 cases. Of the 2 HMB45-negative cases, staining was performed on a cell-block section in 1 lesion (case 11) and on a direct smear in the other (case 25). Positive melan-A staining was observed in all 4 cases tested, and positive SMA was identified in 3 cases tested. Of the 3 FNA cases with an erroneous diagnosis, 1 (case 26) that had been misdiagnosed as RCC had been worked up by immunostaining on cell-block sections, which stained positive for vimentin and CD10, focally positive for cytokeratin, and negative for carcinoembryonic antigen. Upon retrospective review, the cells expressing cytokeratin, vimentin, and CD10 were actually benign renal parenchymal cells and that rare smaller, metastatic neuroendocrine tumor cells were also positive for cytokeratin. Of the 3 masses in the liver (cases 29, 30, and 33), immunostains were performed in 2. One tumor (case 29) was a primary AML and was cytologically composed of spindle and epithelioid cells. The other tumor (case 33) was a metastatic AML and was composed predominantly of epithelioid cells. In both cases, hepatocellular markers, such as HepPar1 and glypican3, were included, indicating that hepatocellular carcinoma was considered in the differential diagnosis.
DISCUSSION
AML masses that are subject to pathologic evaluation are often those that fail to demonstrate typical AML radiologic findings and/or have other clinical issues, such as bleeding or pain. A definitive diagnosis of AML is usually straightforward with a surgical pathology sample; however, it can be difficult on an FNA sample, not only because AML is a rare tumor and uncommonly encountered in cytology practice but also because of the intrinsic limitations of FNA specimens.
In our series, 18 patients had a history of malignancy other than AML, and metastatic neoplasms were often a clinical concern. Radiologically, AML was considered in the differential diagnosis in only 12 cases because of the presence of fat component. It is noteworthy that RCC was considered in 9 cases. Furthermore, classic radiologic features of AML were not identified in the 5 extrarenal lesions (3 in the liver, 1 in the abdominal wall, and 1 in the lung) or in 2 of the 3 masses with an erroneous FNA diagnosis. Apparently, atypical radiologic findings can make an FNA diagnosis more challenging.
Large renal masses with extension to the retroperitoneum can also cause diagnostic puzzling. The FNA diagnosis of all 3 large masses involving the retroperitoneum was descriptive. It is possible that the retroperitoneal location broadened the differential diagnosis; tumors that are commonly observed in this area, such as atypical lipomatous tumor or liposarcoma, may also be considered. 15 Notably, a fat component was indeed identified on imaging in 2 of the 3 cases. Leiomyosarcoma may also be included in the differential diagnosis given the retroperitoneal location and the fact that most AMLs are composed predominantly of spindle cells and are positive for SMA. The cytologic findings of AML described in the literature are similar to what we observed in this series, and smooth-muscle cells are more commonly found than the other 2 components. 14, 15, [17] [18] [19] [20] [21] [22] In the current study, all 25 cases with available cytomorphologic information had a smooth-muscle component. Adipose tissue was identified in 8 cases, and a vascular component was identified in 11 cases. Only 6 cases contained all 3 components. Therefore, the lack of 1 or 2 components is not uncommon in FNA samples. Epithelioid AML is composed predominantly of epithelioid cells. The number of epithelioid cells varies among previous studies. [6] [7] [8] According to the recently published World Health Organization classification, at least 80% epithelial cells in the histologic section are required to make this diagnosis. 1 Because of the epithelioid appearance and presence of nuclear atypia in some cases, the cytologic features may mimic carcinoma. [18] [19] [20] [21] [22] However, the immunophenotype of epithelioid AML is similar to that of the usual AML. [6] [7] [8] Knowledge of epithelioid AML and its cytologic features is important to prevent erroneous FNA diagnoses.
Notably, compared with usual AML, epithelioid AML tends to be large in size and fat-poor on radiologic images, 23 which can contribute to the diagnostic dilemma.
Furthermore, epithelioid AML, especially that exhibiting atypical cytologic features, is associated with aggressive biologic behavior, such as recurrence and/or metastasis. [6] [7] [8] Consistent with the findings reported in the literature, all 3 cases of metastatic AML in the current series had predominantly epithelioid cells. Because of the diagnostic difficulty in some cases, immunostaining is often required for making a definitive diagnosis. Typically, AML is positive for melanocytic and smooth-muscle markers, including HMB45, microphthalmia-associated transcription factor, melan-A, and SMA, but negative for cytokeratin. 2, 16, 17, 24, 25 Cathepsin K has recently been used as a new diagnostic marker for both usual and epithelioid AML. 26 Consistent with these findings, we observed positive HMB45 staining in 8 of 10 AML cases. Melan-A and SMA were positive in all cases tested. It is noteworthy that the expression of melanocytic markers by AML makes melanoma an important differential diagnosis, especially when the tumor is predominantly epithelioid and/or in an extrarenal location. The FNA diagnosis in case 29 would have been difficult if histologic information and immunostaining in a concurrent core-needle biopsy had not been available. The patient had a history of uveal melanoma, and the liver mass was identified and aspirated. The factors that may lead to a misdiagnosis of metastatic melanoma in this case are as follows: 1) uveal melanoma almost exclusively metastasizes to the liver, whereas AML rarely occurs in the liver; 2) the radiologic findings raise a concern for metastatic melanoma or hepatocellular carcinoma, but not AML; 3) a mixture of spindle and epithelioid cells can be observed in melanoma; and 4) a positive reaction with melanoma markers (HMB45 and melan-A) can lead to a diagnosis of melanoma. Likewise, AML should not be misdiagnosed as leiomyosarcoma because of SMA positivity, especially when it is predominantly composed of spindle cells and/or involves the retroperitoneum. Primary AML in an extrarenal location is rare and usually occurs in the liver. 3, 27 There were 2 such cases in the current study, and both were located in the liver. Extrarenal AML shares similar cytologic features with its renal counterpart. The accurate diagnosis of hepatic AML can be challenging, not only because it is rare but also because the liver is a major recipient organ for metastases from various primary origins. In our study, there were 2 AML cases with coexisting metastases from other origins. One patient (case 5) had lesions identified in a lung and kidney. Clinically, an RCC with lung metastasis was considered. The imaging impression of the renal lesion included RCC, metastasis, and AML. An FNA diagnosis of the renal mass was made in correlation with the results from a concurrent surgical biopsy and immunohistochemical staining demonstrating that 1 portion of tumor cells was positive for TTF1 and cytokeratin, and the other portion was positive for HMB45 and SMA, confirming metastatic lung adenocarcinoma in the renal AML. Another patient 26 had a history of metastatic pancreatic neuroendocrine carcinoma in the liver. The imaging impression of the renal lesion included metastatic neuroendocrine carcinoma and a primary renal tumor. The FNA sample had a mixture of spindle and epithelioid cells. An erroneous diagnosis of RCC was rendered, because AML was not considered in the differential diagnosis, and the biomarkers expressed in renal parenchymal cells and coexisting rare neuroendocrine carcinoma cells complicated the interpretation. Subsequent surgical specimen with immunostains detected small clusters of metastatic neuroendocrine carcinoma in AML that were positive for cytokeratin, chromogranin, and synaptophysin. Although tumor-to-tumor metastasis is very rare, it can occur in AML, probably because of a rich vascular supply in AML. 28 Notably, although epithelioid AML may be mistaken for RCC, some of the RCC (especially clear cellpapillary RCC) may exhibit smooth-muscle-rich stroma, which may be misinterpreted as AML in FNA samples. 29, 30 In conclusion, a diagnosis of AML on FNA samples can be challenging. Large tumor size, extrarenal location, atypical radiologic findings, and the presence Original Article
